US-based medical device firm Abbott has secured FDA approval for Navitor to treat people with aortic stenosis who are at high or extreme risk for open heart surgery. Transcatheter aortic valve implantation (TAVI) systems like Navitor can be placed with minimally-invasive surgery, reducing complications resulting from age, fragility or other diseases.
Abbott secures FDA approval for Navitor TAVI device
